Side-by-side comparison of AI visibility scores, market position, and capabilities
Telehealth opioid use disorder treatment with buprenorphine prescribing; removing geographic barriers to MAT for patients in 20+ states through online clinical visits.
Ophelia is a telehealth platform specializing in medication-assisted treatment (MAT) for opioid use disorder, providing access to buprenorphine (Suboxone) through online consultations and prescription management for patients across the United States. Founded in 2019 and headquartered in New York City, Ophelia addresses the severe treatment access gap in opioid addiction care — where millions of Americans with opioid use disorder cannot access MAT due to provider shortages, geographic barriers, stigma, or cost.
Cambridge/Colorado trapped-ion quantum computing (Honeywell majority; $625M+/$5B valuation Jun 2024); Helios Nov 2025 at 98 physical/48 logical qubits with 99.9975% fidelity serving Amgen/BMW/JPMorgan competing with IBM Quantum.
Quantinuum is a Cambridge, UK and Broomfield, Colorado-based integrated quantum computing company — majority owned by Honeywell (NASDAQ: HON) with $625+ million in total funding including a $300 million round led by JPMorgan Chase at a $5 billion valuation in June 2024 — operating the world's most accurate commercial quantum computers using trapped-ion technology combined with quantum software from Cambridge Quantum. In November 2025, Quantinuum launched Helios, its third-generation quantum computer featuring 98 physical qubits and 48 logical error-corrected qubits with 99.9975% single-qubit gate fidelity and 99.921% two-qubit gate fidelity — the highest-accuracy general-purpose commercial quantum computer commercially available. Serving enterprise customers including Amgen (drug discovery), BMW Group (materials simulation), JPMorgan Chase (financial optimization), and SoftBank Corp. (AI acceleration), Quantinuum was formed in November 2021 through the merger of Honeywell Quantum Solutions and Cambridge Quantum Computing. CEO Ilyas Khan.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.